New Path Molecular Research Competitors and Similar CompaniesClear all

New Path Molecular Research's competitors and similar companies include SillaJen, Alphamab Oncology and X4 Pharmaceuticals.

	New Path Molecular Research New Path Molecular Research is a company that specializes in the chemical synthesis of complex functional molecules.	SillaJen SillaJen is a biotechnology company focused on engineering and developing oncolytic virus immunotherapeutics.	Alphamab Oncology Alphamab Oncology is a clinical-stage biopharmaceutical company.	X4 Pharmaceuticals X4 Pharmaceuticals (formerly known as Arsanis) is a biopharmaceutical company that provides drug development services.
Founding Date	Founding Date 2015	Founding Date 2003	Founding Date 2009	Founding Date 2010
Type	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech chemicals oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech oncology pharma	Tags Healthcare biotech drug development pharma therapy
Locations	Locations Cambridge, GB HQ	Locations KR HQ San Francisco, US	Locations Suzhou Shi, CN HQ	Locations Boston, US HQ Wien, AT
Employees	Employees 620% increase	Employees 4316% increase	Employees 42	Employees 1005% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ₩9.2b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $6.5m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods (₩1k) (FY, 2025)	Cost of goods N/A	Cost of goods $5.8m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ₩9.9b (FY, 2025)	Gross profit N/A	Gross profit $743k (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 12m	Total funding raised $ 160m	Total funding raised $ 64.5m